← All organizations

Vitreoretinal Technologies, Inc.

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2008

Acquired by Numoda on Jul 1, 2012

Timeline

1990s

Jun 1, 1999
Vitreoretinal Technologies, Inc.— Founded

2010s

Jul 1, 2012
Numoda— Acquired By

Drugs by trial phase (1 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

ocriplasmin

Indications

Studied for

Recent trials (2)

NCT00908778Lead sponsorPhase 3Oct 1, 2008
NCT00664183Lead sponsorPhase 2/Phase 3Mar 1, 2008

Details

Founded: Irvine, CA, US Jun 1, 1999
Last known activity: Oct 1, 2008